IGM Biosciences Ownership 2024 | Who Owns IGM Biosciences Now?
Institutional Ownership
1.67%
Insider Ownership
34.70%
Retail Ownership
63.63%
Institutional Holders
21.00
IGM Biosciences Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| BAKER BROS. ADVISORS LP | 6.80% | 0.36% | 4,090,316 | 1,994 | 0.05% | 28,100,471 | Jun 30, 2024 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 6.78% | 0.00% | 4,075,091 | 187,068 | 4.81% | 27,997,000 | Jun 30, 2024 |
| ARTAL GROUP S.A. | 5.54% | 0.58% | 3,330,422 | 250,000 | 8.12% | 22,879,999 | Jun 30, 2024 |
| REDMILE GROUP, LLC | 5.11% | 1.28% | 3,072,478 | - | - | 21,107,924 | Jun 30, 2024 |
| GOLDMAN SACHS GROUP INC | 2.22% | 0.00% | 1,333,913 | 55,294 | 4.32% | 9,163,982 | Jun 30, 2024 |
| BLACKROCK INC. | 1.47% | 0.00% | 883,081 | 125,118 | 16.51% | 6,066,767 | Jun 30, 2024 |
| VANGUARD GROUP INC | 1.46% | 0.00% | 878,621 | 24,963 | 2.92% | 6,036,127 | Jun 30, 2024 |
| FMR LLC | 1.36% | 0.00% | 818,873 | -498,468 | -37.84% | 5,625,658 | Jun 30, 2024 |
| STATE STREET CORP | 0.76% | 0.00% | 457,616 | 138,347 | 43.33% | 3,143,822,000 | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | 0.65% | 0.00% | 391,213 | -303,848 | -43.72% | 2,687,633 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 0.61% | 0.00% | 367,681 | 31,676 | 9.43% | 2,526,253 | Jun 30, 2024 |
| RHENMAN & PARTNERS ASSET MANAGEMENT AB | 0.32% | 0.13% | 195,000 | - | - | 1,339,650 | Jun 30, 2024 |
| TD ASSET MANAGEMENT INC | 0.27% | 0.00% | 164,472 | 5,350 | 3.36% | 1,129,923 | Jun 30, 2024 |
| SAMSARA BIOCAPITAL, LLC | 0.26% | 0.22% | 154,664 | - | - | 1,062,542 | Jun 30, 2024 |
| NORTHERN TRUST CORP | 0.22% | 0.00% | 134,727 | -2,509 | -1.83% | 925,574,000 | Jun 30, 2024 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 0.22% | 0.00% | 132,330 | 11,212 | 9.26% | 909,107 | Jun 30, 2024 |
| D. E. SHAW & CO., INC. | 0.22% | 0.00% | 131,065 | 37,902 | 40.68% | 900,416 | Jun 30, 2024 |
| MORGAN STANLEY | 0.19% | 0.00% | 111,511 | 10,416 | 10.30% | 766,080 | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | 0.18% | 0.00% | 108,693 | 60,593 | 125.97% | 746,721 | Jun 30, 2024 |
| MARSHALL WACE, LLP | 0.18% | 0.00% | 107,267 | 36,491 | 51.56% | 736,925 | Jun 30, 2024 |
IGM Biosciences's largest institutional shareholder is BAKER BROS. ADVISORS LP, holding 6.80% of the company's total share outstanding, currently valued at $28.10M. The top 10 institutional shareholders own together 32.16% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| REDMILE GROUP, LLC | 5.11% | 1.28% | 3,072,478 | - | - | 21,107,924 | Jun 30, 2024 |
| ARTAL GROUP S.A. | 5.54% | 0.58% | 3,330,422 | 250,000 | 8.12% | 22,879,999 | Jun 30, 2024 |
| BAKER BROS. ADVISORS LP | 6.80% | 0.36% | 4,090,316 | 1,994 | 0.05% | 28,100,471 | Jun 30, 2024 |
| CORTON CAPITAL INC. | 0.11% | 0.23% | 63,336 | 63,336 | 100.00% | 435,118 | Jun 30, 2024 |
| BRUCE & CO., INC. | 0.17% | 0.23% | 100,000 | 35,000 | 53.85% | 687,000 | Jun 30, 2024 |
| SAMSARA BIOCAPITAL, LLC | 0.26% | 0.22% | 154,664 | - | - | 1,062,542 | Jun 30, 2024 |
| EAGLE BAY ADVISORS LLC | 0.07% | 0.19% | 44,635 | - | - | 306,642 | Jun 30, 2024 |
| RHENMAN & PARTNERS ASSET MANAGEMENT AB | 0.32% | 0.13% | 195,000 | - | - | 1,339,650 | Jun 30, 2024 |
| PENNANT INVESTORS, LP | 0.11% | 0.12% | 64,900 | - | - | 445,863 | Jun 30, 2024 |
| VIRTUS ETF ADVISERS LLC | 0.02% | 0.04% | 11,401 | -1,931 | -14.48% | 78,325 | Jun 30, 2024 |
| GSA CAPITAL PARTNERS LLP | 0.10% | 0.03% | 61,981 | 43,583 | 236.89% | 426,000 | Jun 30, 2024 |
| XTX TOPCO LTD | 0.03% | 0.01% | 20,408 | 8,467 | 70.91% | 140,203 | Jun 30, 2024 |
| QUEST PARTNERS LLC | 0.02% | 0.01% | 11,913 | 4,961 | 71.36% | 81,842 | Jun 30, 2024 |
| SUSQUEHANNA PORTFOLIO STRATEGIES, LLC | 0.05% | 0.01% | 30,209 | - | - | 207,536 | Jun 30, 2024 |
| WOODLINE PARTNERS LP | 0.12% | 0.00% | 75,000 | - | - | 515,250 | Jun 30, 2024 |
| EXCHANGE TRADED CONCEPTS, LLC | 0.04% | 0.00% | 21,307 | -6,628 | -23.73% | 146,379 | Jun 30, 2024 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 6.78% | 0.00% | 4,075,091 | 187,068 | 4.81% | 27,997,000 | Jun 30, 2024 |
| EXODUSPOINT CAPITAL MANAGEMENT, LP | 0.12% | 0.00% | 71,503 | 51,180 | 251.83% | 491,000 | Jun 30, 2024 |
| JUMP FINANCIAL, LLC | 0.03% | 0.00% | 19,200 | 19,200 | 100.00% | 131,904 | Jun 30, 2024 |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | 0.03% | 0.00% | 16,028 | -11,703 | -42.20% | 110,112 | Jun 30, 2024 |
The largest IGM Biosciences shareholder by % of total assets is REDMILE GROUP, LLC. The company owns 3.07M shares of IGM Biosciences (IGMS), representing 1.28% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| ARTAL GROUP S.A. | 5.54% | 0.58% | 3,330,422 | 250,000 | 8.12% | 22,879,999 | Jun 30, 2024 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 6.78% | 0.00% | 4,075,091 | 187,068 | 4.81% | 27,997,000 | Jun 30, 2024 |
| STATE STREET CORP | 0.76% | 0.00% | 457,616 | 138,347 | 43.33% | 3,143,822,000 | Jun 30, 2024 |
| BLACKROCK INC. | 1.47% | 0.00% | 883,081 | 125,118 | 16.51% | 6,066,767 | Jun 30, 2024 |
| CORTON CAPITAL INC. | 0.11% | 0.23% | 63,336 | 63,336 | 100.00% | 435,118 | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | 0.18% | 0.00% | 108,693 | 60,593 | 125.97% | 746,721 | Jun 30, 2024 |
| GOLDMAN SACHS GROUP INC | 2.22% | 0.00% | 1,333,913 | 55,294 | 4.32% | 9,163,982 | Jun 30, 2024 |
| EXODUSPOINT CAPITAL MANAGEMENT, LP | 0.12% | 0.00% | 71,503 | 51,180 | 251.83% | 491,000 | Jun 30, 2024 |
| HUDSON BAY CAPITAL MANAGEMENT LP | 0.08% | 0.00% | 46,119 | 46,119 | 100.00% | 316,838 | Jun 30, 2024 |
| GSA CAPITAL PARTNERS LLP | 0.10% | 0.03% | 61,981 | 43,583 | 236.89% | 426,000 | Jun 30, 2024 |
| D. E. SHAW & CO., INC. | 0.22% | 0.00% | 131,065 | 37,902 | 40.68% | 900,416 | Jun 30, 2024 |
| MARSHALL WACE, LLP | 0.18% | 0.00% | 107,267 | 36,491 | 51.56% | 736,925 | Jun 30, 2024 |
| BRUCE & CO., INC. | 0.17% | 0.23% | 100,000 | 35,000 | 53.85% | 687,000 | Jun 30, 2024 |
| TWO SIGMA INVESTMENTS, LP | 0.08% | 0.00% | 50,347 | 33,012 | 190.44% | 345,884 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 0.61% | 0.00% | 367,681 | 31,676 | 9.43% | 2,526,253 | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | 0.05% | 0.00% | 30,000 | 30,000 | 100.00% | 206,100 | Jun 30, 2024 |
| POINT72 ASSET MANAGEMENT, L.P. | 0.05% | 0.00% | 27,246 | 27,246 | 100.00% | 187,178 | Jun 30, 2024 |
| VERITION FUND MANAGEMENT LLC | 0.04% | 0.00% | 26,120 | 26,120 | 100.00% | 179,444 | Jun 30, 2024 |
| VANGUARD GROUP INC | 1.46% | 0.00% | 878,621 | 24,963 | 2.92% | 6,036,127 | Jun 30, 2024 |
| ROYAL BANK OF CANADA | 0.04% | - | 22,340 | 22,038 | 7297.35% | 154,000 | Jun 30, 2024 |
As of Jun 30 2024, IGM Biosciences's largest institutional buyer is ARTAL GROUP S.A.. The company purchased 250.00K stocks of IGMS, valued at $22.88M.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | - | - | - | -937,500 | -100.00% | - | Jun 30, 2024 |
| FMR LLC | 1.36% | 0.00% | 818,873 | -498,468 | -37.84% | 5,625,658 | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | 0.65% | 0.00% | 391,213 | -303,848 | -43.72% | 2,687,633 | Jun 30, 2024 |
| JACOBS LEVY EQUITY MANAGEMENT, INC | - | - | - | -78,580 | -100.00% | - | Jun 30, 2024 |
| TREXQUANT INVESTMENT LP | - | - | - | -24,177 | -100.00% | - | Jun 30, 2024 |
| WALLEYE CAPITAL LLC | - | - | - | -20,050 | -100.00% | - | Jun 30, 2024 |
| ENTRYPOINT CAPITAL, LLC | - | - | - | -15,801 | -100.00% | - | Jun 30, 2024 |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | 0.03% | 0.00% | 16,028 | -11,703 | -42.20% | 110,112 | Jun 30, 2024 |
| PALE FIRE CAPITAL SE | - | - | - | -11,601 | -100.00% | - | Jun 30, 2024 |
| BREVAN HOWARD CAPITAL MANAGEMENT LP | - | - | - | -10,589 | -100.00% | - | Jun 30, 2024 |
| CERITY PARTNERS LLC | - | - | - | -10,513 | -100.00% | - | Jun 30, 2024 |
| METLIFE INVESTMENT MANAGEMENT, LLC | - | - | - | -7,248 | -100.00% | - | Jun 30, 2024 |
| EXCHANGE TRADED CONCEPTS, LLC | 0.04% | 0.00% | 21,307 | -6,628 | -23.73% | 146,379 | Jun 30, 2024 |
| AMERICAN INTERNATIONAL GROUP, INC. | - | - | - | -6,549 | -100.00% | - | Jun 30, 2024 |
| UBS GROUP AG | 0.01% | - | 8,407 | -4,924 | -36.94% | 57,756 | Jun 30, 2024 |
| BARCLAYS PLC | 0.02% | - | 14,527 | -4,527 | -23.76% | 101,000 | Jun 30, 2024 |
| ADAR1 CAPITAL MANAGEMENT, LLC | - | - | - | -4,000 | -100.00% | - | Jun 30, 2024 |
| NORTHERN TRUST CORP | 0.22% | 0.00% | 134,727 | -2,509 | -1.83% | 925,574,000 | Jun 30, 2024 |
| DIMENSIONAL FUND ADVISORS LP | 0.06% | 0.00% | 37,034 | -2,419 | -6.13% | 254,369 | Jun 30, 2024 |
| VIRTUS ETF ADVISERS LLC | 0.02% | 0.04% | 11,401 | -1,931 | -14.48% | 78,325 | Jun 30, 2024 |
As of Jun 30 2024, IGM Biosciences's biggest institutional seller is RA CAPITAL MANAGEMENT, L.P.. The company sold -0.94M shares of IGMS, valued at -.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| CORTON CAPITAL INC. | 0.11% | 0.23% | 63,336 | 63,336 | 100.00% | 435,118 | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | 0.05% | 0.00% | 30,000 | 30,000 | 100.00% | 206,100 | Jun 30, 2024 |
| POINT72 ASSET MANAGEMENT, L.P. | 0.05% | 0.00% | 27,246 | 27,246 | 100.00% | 187,178 | Jun 30, 2024 |
| VERITION FUND MANAGEMENT LLC | 0.04% | 0.00% | 26,120 | 26,120 | 100.00% | 179,444 | Jun 30, 2024 |
| JUMP FINANCIAL, LLC | 0.03% | 0.00% | 19,200 | 19,200 | 100.00% | 131,904 | Jun 30, 2024 |
| TUDOR INVESTMENT CORP ET AL | 0.02% | 0.00% | 14,537 | 14,537 | 100.00% | 99,869 | Jun 30, 2024 |
| AQR CAPITAL MANAGEMENT LLC | 0.02% | 0.00% | 12,230 | 12,230 | 100.00% | 84,020 | Jun 30, 2024 |
| COREBRIDGE FINANCIAL, INC. | 0.01% | 0.00% | 8,162 | 8,162 | 100.00% | 56,073 | Jun 30, 2024 |
| MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 0.01% | 0.00% | 6,508 | 6,508 | 100.00% | 44,710 | Jun 30, 2024 |
| CUBIST SYSTEMATIC STRATEGIES, LLC | 0.01% | 0.00% | 3,300 | 3,300 | 100.00% | 22,673 | Jun 30, 2024 |
| QUARRY LP | 0.00% | 0.00% | 197 | 197 | 100.00% | 1,353 | Jun 30, 2024 |
| ADVISOR GROUP HOLDINGS, INC. | 0.00% | - | 59 | 59 | 100.00% | 405 | Jun 30, 2024 |
IGM Biosciences's largest new institutional shareholder by number of shares is CORTON CAPITAL INC., purchased 63.34K shares, valued at $435.12K, as of undefined.
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | - | - | - | -937,500 | -100.00% | - | Jun 30, 2024 |
| JACOBS LEVY EQUITY MANAGEMENT, INC | - | - | - | -78,580 | -100.00% | - | Jun 30, 2024 |
| TREXQUANT INVESTMENT LP | - | - | - | -24,177 | -100.00% | - | Jun 30, 2024 |
| WALLEYE CAPITAL LLC | - | - | - | -20,050 | -100.00% | - | Jun 30, 2024 |
| ENTRYPOINT CAPITAL, LLC | - | - | - | -15,801 | -100.00% | - | Jun 30, 2024 |
| PALE FIRE CAPITAL SE | - | - | - | -11,601 | -100.00% | - | Jun 30, 2024 |
| BREVAN HOWARD CAPITAL MANAGEMENT LP | - | - | - | -10,589 | -100.00% | - | Jun 30, 2024 |
| CERITY PARTNERS LLC | - | - | - | -10,513 | -100.00% | - | Jun 30, 2024 |
| METLIFE INVESTMENT MANAGEMENT, LLC | - | - | - | -7,248 | -100.00% | - | Jun 30, 2024 |
| AMERICAN INTERNATIONAL GROUP, INC. | - | - | - | -6,549 | -100.00% | - | Jun 30, 2024 |
| ADAR1 CAPITAL MANAGEMENT, LLC | - | - | - | -4,000 | -100.00% | - | Jun 30, 2024 |
| NVERSES CAPITAL, LLC | - | - | - | -1,600 | -100.00% | - | Jun 30, 2024 |
| QUANTBOT TECHNOLOGIES LP | - | - | - | -800 | -100.00% | - | Jun 30, 2024 |
| METROPOLITAN LIFE INSURANCE CO/NY | - | - | - | -749 | -100.00% | - | Jun 30, 2024 |
| HANSEATIC MANAGEMENT SERVICES INC | - | - | - | -366 | -100.00% | - | Jun 30, 2024 |
| GAMMA INVESTING LLC | - | - | - | -76 | -100.00% | - | Jun 30, 2024 |
| NELSON, VAN DENBURG & CAMPBELL WEALTH MANAGEMENT GROUP, LLC | - | - | - | -3 | -100.00% | - | Jun 30, 2024 |
IGM Biosciences's largest sold out institutional shareholder by shares sold is RA CAPITAL MANAGEMENT, L.P., sold -0.94M shares, valued at -, as of undefined.
IGM Biosciences Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| T. Rowe Price New Horizons Fund, Inc. | 0.37% | 1,852,696 | -13,794 | -0.74% | Mar 31, 2024 |
| T. Rowe Price Health Sciences Fund, Inc. | 0.29% | 965,758 | 526,787 | 120.00% | Mar 31, 2024 |
| ALGER FUNDS | 0.06% | 62,152 | - | - | Jan 31, 2024 |
| T. Rowe Price Small-Cap Stock Fund, Inc. | 0.06% | 209,619 | - | - | Mar 31, 2024 |
| T. Rowe Price Small-Cap Value Fund, Inc. | 0.05% | 392,244 | - | - | Mar 31, 2024 |
| T. Rowe Price Quantitative Management Funds, Inc. | 0.05% | 153,124 | 1,609 | 1.06% | Mar 31, 2024 |
| Humankind Benefit Corp | 0.03% | 717 | - | - | Dec 31, 2023 |
| Advantage Advisers Xanthus Fund, L.L.C. | 0.03% | 95,175 | - | - | Mar 31, 2024 |
| BRUCE FUND INC | 0.03% | 65,000 | -55,000 | -45.83% | Dec 31, 2023 |
| T. Rowe Price Equity Series, Inc. | 0.03% | 44,463 | 18,696 | 72.56% | Mar 31, 2024 |
| FIDELITY SELECT PORTFOLIOS | 0.02% | 1,539,782 | -148,700 | -8.81% | Feb 29, 2024 |
| VANGUARD VALLEY FORGE FUNDS | 0.02% | 8,083 | - | - | Mar 31, 2024 |
| T. Rowe Price Equity Funds, Inc. | 0.01% | 107,703 | - | - | Mar 31, 2024 |
| IndexIQ ETF Trust | 0.01% | 21,441 | - | - | Jan 31, 2024 |
| ETFis Series Trust I | 0.01% | 12,625 | 2,716 | 27.41% | Jan 31, 2024 |
| FIDELITY ADVISOR SERIES VII | 0.01% | 55,100 | - | - | Jan 31, 2024 |
| ACAP Strategic Fund | 0.01% | 73,366 | - | - | Mar 31, 2024 |
| QUANTITATIVE MASTER SERIES LLC | 0.00% | 21,795 | - | - | Mar 31, 2024 |
| UBS FUNDS | 0.00% | 15,791 | - | - | Mar 31, 2024 |
| DEUTSCHE DWS INVESTMENTS VIT FUNDS | 0.00% | 1,804 | - | - | Mar 31, 2024 |
| VICTORY PORTFOLIOS | 0.00% | 59,410 | - | - | Mar 31, 2024 |
| FIDELITY COMMONWEALTH TRUST | 0.00% | 5,676 | - | - | Feb 29, 2024 |
| VANGUARD INDEX FUNDS | 0.00% | 724,701 | -333,528 | -31.52% | Mar 31, 2024 |
| T. Rowe Price Index Trust, Inc. | 0.00% | 35,935 | 3,173 | 9.69% | Mar 31, 2024 |
| Nushares ETF Trust | 0.00% | 10,458 | - | - | Jan 31, 2024 |
| BNY Mellon Strategic Funds, Inc. | 0.00% | 3,140 | - | - | Mar 31, 2024 |
| GOLDMAN SACHS VARIABLE INSURANCE TRUST | 0.00% | 4,399 | - | - | Mar 31, 2024 |
| ETF Series Solutions | 0.00% | 22,410 | 3,589 | 19.07% | Feb 29, 2024 |
| TIAA SEPARATE ACCOUNT VA 1 | 0.00% | 229 | - | - | Mar 31, 2024 |
| SCHWAB CAPITAL TRUST | 0.00% | 36,324 | 4,474 | 14.05% | Jan 31, 2024 |
| T. Rowe Price Spectrum Funds II, Inc. | 0.00% | 11,332 | - | - | Feb 29, 2024 |
| FIDELITY CONCORD STREET TRUST | 0.00% | 156,391 | -5,521 | -3.41% | Feb 29, 2024 |
| Fidelity Commonwealth Trust II | 0.00% | 4,636 | - | - | Aug 31, 2023 |
| PUTNAM ASSET ALLOCATION FUNDS | 0.00% | 17,780 | - | - | Mar 31, 2024 |
| NUVEEN INVESTMENT FUNDS INC | 0.00% | 18,306 | - | - | Jan 31, 2024 |
| Calvert Variable Products, Inc. | 0.00% | 1,327 | 700 | 111.64% | Mar 31, 2024 |
| FIDELITY COVINGTON TRUST | 0.00% | 8,484 | - | - | Jan 31, 2024 |
| Principal Exchange-Traded Funds | 0.00% | 5,265 | -334 | -5.97% | Mar 31, 2024 |
| Direxion Shares ETF Trust | 0.00% | 66,122 | - | - | Jan 31, 2024 |
| VANGUARD INSTITUTIONAL INDEX FUNDS | 0.00% | 9,125 | -716 | -7.28% | Mar 31, 2024 |
| NEW COVENANT FUNDS | 0.00% | 1,084 | - | - | Dec 31, 2023 |
| VANGUARD WORLD FUND | 0.00% | 55,909 | 10,351 | 22.72% | Feb 29, 2024 |
| PRUDENTIAL INVESTMENT PORTFOLIOS, INC. | 0.00% | 2,100 | - | - | Mar 28, 2024 |
| VANGUARD HORIZON FUNDS | 0.00% | 4,585 | - | - | Mar 31, 2024 |
| SCHWAB STRATEGIC TRUST | 0.00% | 86,712 | 17,817 | 25.86% | Feb 29, 2024 |
| Voya VARIABLE PORTFOLIOS INC | 0.00% | 4,549 | -2,062 | -31.19% | Mar 31, 2024 |
| TIAA-CREF LIFE FUNDS | 0.00% | 344 | - | - | Mar 31, 2024 |
| SunAmerica Specialty Series | 0.00% | 59 | - | - | Apr 30, 2021 |
| STATE STREET VARIABLE INSURANCE SERIES FUNDS INC | 0.00% | 539 | - | - | Mar 31, 2024 |
| VANGUARD VARIABLE INSURANCE FUNDS | 0.00% | 5,239 | - | - | Mar 31, 2024 |
| NORTHERN FUNDS | 0.00% | 14,133 | -1,743 | -10.98% | Mar 28, 2024 |
| Global X Funds | 0.00% | 4,241 | - | - | Jan 31, 2024 |
| STATE STREET INSTITUTIONAL INVESTMENT TRUST | 0.00% | 4,900 | - | - | Mar 31, 2024 |
| AMERICAN CENTURY ETF TRUST | 0.00% | 8,321 | 5,310 | 176.35% | Feb 29, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND II | 0.00% | 878 | -159 | -15.33% | Mar 31, 2024 |
| Victory Portfolios II | 0.00% | 3,117 | - | - | Mar 31, 2024 |
| FLEXSHARES TRUST | 0.00% | 4,654 | - | - | Jan 31, 2024 |
| EQ ADVISORS TRUST | 0.00% | 66,176 | 1,867 | 2.90% | Mar 31, 2024 |
| Meeder Funds | 0.00% | 247 | - | - | Mar 31, 2024 |
| Dimensional ETF Trust | 0.00% | 18,430 | - | - | Jan 31, 2024 |
| ALLSPRING MASTER TRUST | 0.00% | 2,670 | - | - | Feb 29, 2024 |
| ALLIANZ VARIABLE INSURANCE PRODUCTS TRUST | 0.00% | 1,919 | - | - | Dec 31, 2023 |
| GPS Funds I | 0.00% | 186 | - | - | Mar 31, 2024 |
| RUSSELL INVESTMENT CO | 0.00% | 10,321 | - | - | Jan 31, 2024 |
| SEASONS SERIES TRUST | 0.00% | 774 | - | - | Mar 31, 2024 |
| Brighthouse Funds Trust II | 0.00% | 27,375 | 4,607 | 20.23% | Mar 31, 2024 |
| VANGUARD SCOTTSDALE FUNDS | 0.00% | 58,625 | 12,427 | 26.90% | Feb 29, 2024 |
| iSHARES TRUST | 0.00% | 472,438 | -23,140 | -4.67% | Mar 31, 2024 |
| RYDEX SERIES FUNDS | 0.00% | 109 | - | - | Dec 31, 2023 |
| VANGUARD WELLINGTON FUND | 0.00% | 10,348 | - | - | Feb 29, 2024 |
| ADVANCED SERIES TRUST | 0.00% | 78,150 | -16,200 | -17.17% | Mar 28, 2024 |
| VANGUARD QUANTITATIVE FUNDS | 0.00% | 100 | - | - | Mar 31, 2024 |
| VALIC Co I | 0.00% | 5,099 | 502 | 10.92% | Feb 29, 2024 |
| MASTER INVESTMENT PORTFOLIO | 0.00% | 1,536 | - | - | Mar 31, 2024 |
| Invesco Exchange-Traded Fund Trust II | 0.00% | 4,916 | -374 | -7.07% | Feb 29, 2024 |
| RUSSELL INVESTMENT FUNDS | 0.00% | 1,772 | - | - | Mar 31, 2024 |
| SPDR SERIES TRUST | 0.00% | 584,389 | - | - | Mar 31, 2024 |
| TRANSAMERICA SERIES TRUST | 0.00% | 13,760 | - | - | Mar 31, 2024 |
| Pacer Funds Trust | 0.00% | 617 | - | - | Jan 31, 2024 |
| NATIONWIDE VARIABLE INSURANCE TRUST | 0.00% | 1,799 | - | - | Mar 31, 2024 |
| RYDEX DYNAMIC FUNDS | 0.00% | 54 | - | - | Dec 31, 2023 |
| Goldman Sachs ETF Trust | 0.00% | 1,259 | - | - | Feb 29, 2024 |
| TIAA-CREF FUNDS | 0.00% | 37,241 | -7,528 | -16.82% | Jan 31, 2024 |
| USAA MUTUAL FUNDS TRUST | 0.00% | 2,775 | 500 | 21.98% | Jan 31, 2024 |
| J.P. Morgan Exchange-Traded Fund Trust | 0.00% | 4,823 | - | - | Jan 31, 2024 |
| PENN SERIES FUNDS INC | 0.00% | 300 | - | - | Mar 28, 2024 |
| NATIONWIDE MUTUAL FUNDS | 0.00% | 1,282 | -18 | -1.38% | Jan 31, 2024 |
| SUNAMERICA SERIES TRUST | 0.00% | 3,630 | 148 | 4.25% | Jan 31, 2024 |
| JOHN HANCOCK VARIABLE INSURANCE TRUST | 0.00% | 21,360 | 7,809 | 57.63% | Mar 31, 2024 |
| ProFunds | 0.00% | 104 | -8 | -7.14% | Mar 31, 2024 |
| Guggenheim Active Allocation Fund | 0.00% | 48 | - | - | Feb 29, 2024 |
| HC CAPITAL TRUST | 0.00% | 251 | - | - | Mar 31, 2024 |
| PROSHARES TRUST | 0.00% | 1,946 | -1,686 | -46.42% | Feb 29, 2024 |
| MASSMUTUAL SELECT FUNDS | 0.00% | 6,399 | - | - | Dec 31, 2023 |
| RYDEX VARIABLE TRUST | 0.00% | 7 | - | - | Dec 31, 2023 |
| LINCOLN VARIABLE INSURANCE PRODUCTS TRUST | 0.00% | 10,200 | - | - | Mar 31, 2024 |
| Brinker Capital Destinations Trust | 0.00% | 239 | 239 | - | Feb 29, 2024 |
| SPDR INDEX SHARES FUNDS | 0.00% | 747 | - | - | Mar 31, 2024 |
| MORGAN STANLEY PATHWAY FUNDS | 0.00% | 297 | - | - | Feb 29, 2024 |
| T. Rowe Price Multi-Strategy Total Return Fund, Inc. | 0.00% | 442 | - | - | Jan 31, 2024 |
IGM Biosciences's largest mutual fund holder by % of total assets is "T. Rowe Price New Horizons Fund, Inc.", owning 1.85M shares, compromising 0.37% of its total assets.
IGM Biosciences Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 30 Jun, 24 | 21 | -76.14% |
| 31 Mar, 24 | 88 | 18.92% |
| 31 Dec, 23 | 74 | -8.64% |
| 30 Sep, 23 | 81 | -1.22% |
| 30 Jun, 23 | 82 | 5.13% |
| 31 Mar, 23 | 78 | -7.14% |
| 31 Dec, 22 | 84 | -10.64% |
| 30 Sep, 22 | 94 | 2.17% |
| 30 Jun, 22 | 92 | -16.36% |
| 31 Mar, 22 | 110 | 22.22% |
| 31 Dec, 21 | 90 | -23.73% |
| 30 Sep, 21 | 118 | 6.31% |
| 30 Jun, 21 | 111 | -7.50% |
| 31 Mar, 21 | 120 | 6.19% |
| 31 Dec, 20 | 113 | 10.78% |
| 30 Sep, 20 | 102 | 27.50% |
| 30 Jun, 20 | 80 | 29.03% |
| 31 Mar, 20 | 62 | 24.00% |
| 31 Dec, 19 | 50 | 51.52% |
| 30 Sep, 19 | 33 | - |
As of 30 Jun 24, 21 institutions are holding IGM Biosciences's shares, representing a decrease of -76.14% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 30 Jun, 24 | 1,004,741 | -95.60% |
| 31 Mar, 24 | 22,815,546 | 4.28% |
| 31 Dec, 23 | 21,879,400 | -1.96% |
| 30 Sep, 23 | 22,316,970 | 0.26% |
| 30 Jun, 23 | 22,259,304 | 24.70% |
| 31 Mar, 23 | 17,850,754 | -0.70% |
| 31 Dec, 22 | 17,976,799 | 1.63% |
| 30 Sep, 22 | 17,687,867 | 1.07% |
| 30 Jun, 22 | 17,501,332 | -4.09% |
| 31 Mar, 22 | 18,248,577 | 3.47% |
| 31 Dec, 21 | 17,636,538 | 4.40% |
| 30 Sep, 21 | 16,893,682 | 3.42% |
| 30 Jun, 21 | 16,335,074 | -9.22% |
| 31 Mar, 21 | 17,994,317 | 4.79% |
| 31 Dec, 20 | 17,171,417 | 17.11% |
| 30 Sep, 20 | 14,662,588 | 4.61% |
| 30 Jun, 20 | 14,016,992 | 5.61% |
| 31 Mar, 20 | 13,271,932 | 8.82% |
| 31 Dec, 19 | 12,196,539 | 21.54% |
| 30 Sep, 19 | 10,035,118 | - |
IGM Biosciences (IGMS) has 1.00M shares outstanding as of 30 Jun 24, down -95.60% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 30 Jun, 24 | 1.67% | 0.11% |
| 31 Mar, 24 | 38.13% | 2.83% |
| 31 Dec, 23 | 36.72% | 1.50% |
| 30 Sep, 23 | 49.46% | 1.97% |
| 30 Jun, 23 | 50.06% | 3.11% |
| 31 Mar, 23 | 40.14% | 2.14% |
| 31 Dec, 22 | 43.27% | 2.68% |
| 30 Sep, 22 | 40.17% | 2.53% |
| 30 Jun, 22 | 39.85% | 1.37% |
| 31 Mar, 22 | 53.93% | 1.94% |
| 31 Dec, 21 | 52.68% | 2.06% |
| 30 Sep, 21 | 50.52% | 2.11% |
| 30 Jun, 21 | 48.95% | 1.68% |
| 31 Mar, 21 | 53.99% | 1.79% |
| 31 Dec, 20 | 54.86% | 2.40% |
| 30 Sep, 20 | 47.84% | 2.27% |
| 30 Jun, 20 | 45.88% | 2.42% |
| 31 Mar, 20 | 43.53% | 2.72% |
| 31 Dec, 19 | 40.02% | 3.69% |
| 30 Sep, 19 | 32.92% | - |
As of 30 Jun 24, IGM Biosciences is held by 1.67% institutional shareholders, representing a 0.11% growth compared to 31 Mar 24.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 14 | -70.83% |
| 31 Mar, 24 | 48 | 29.73% |
| 31 Dec, 23 | 37 | -11.90% |
| 30 Sep, 23 | 42 | -25.00% |
| 30 Jun, 23 | 56 | 47.37% |
| 31 Mar, 23 | 38 | -9.52% |
| 31 Dec, 22 | 42 | -8.70% |
| 30 Sep, 22 | 46 | -2.13% |
| 30 Jun, 22 | 47 | -27.69% |
| 31 Mar, 22 | 65 | 32.65% |
| 31 Dec, 21 | 49 | - |
| 30 Sep, 21 | 49 | -14.04% |
| 30 Jun, 21 | 57 | -3.39% |
| 31 Mar, 21 | 59 | -1.67% |
| 31 Dec, 20 | 60 | 36.36% |
| 30 Sep, 20 | 44 | -27.87% |
| 30 Jun, 20 | 61 | 69.44% |
| 31 Mar, 20 | 36 | -7.69% |
| 31 Dec, 19 | 39 | 18.18% |
| 30 Sep, 19 | 33 | - |
14 institutional shareholders have increased their position in IGMS stock as of 30 Jun 24 compared to 48 in the previous quarter (a -70.83% decrease).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 3 | -85.71% |
| 31 Mar, 24 | 21 | - |
| 31 Dec, 23 | 21 | -4.55% |
| 30 Sep, 23 | 22 | 29.41% |
| 30 Jun, 23 | 17 | -34.62% |
| 31 Mar, 23 | 26 | 13.04% |
| 31 Dec, 22 | 23 | -17.86% |
| 30 Sep, 22 | 28 | -3.45% |
| 30 Jun, 22 | 29 | 70.59% |
| 31 Mar, 22 | 17 | -19.05% |
| 31 Dec, 21 | 21 | -36.36% |
| 30 Sep, 21 | 33 | -2.94% |
| 30 Jun, 21 | 34 | -5.56% |
| 31 Mar, 21 | 36 | 2.86% |
| 31 Dec, 20 | 35 | -2.78% |
| 30 Sep, 20 | 36 | 200.00% |
| 30 Jun, 20 | 12 | -29.41% |
| 31 Mar, 20 | 17 | 325.00% |
| 31 Dec, 19 | 4 | - |
| 30 Sep, 19 | - | - |
3 institutional shareholders have reduced their position in IGMS stock as of 30 Jun 24 compared to 21 in the previous quarter (a -85.71% decrease).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 30 Jun, 24 | 21 | -76.14% | 1,004,741 | -95.60% | 1.67% | 0.11% | 14 | -70.83% | 3 | -85.71% |
| 31 Mar, 24 | 88 | 18.92% | 22,815,546 | 4.28% | 38.13% | 2.83% | 48 | 29.73% | 21 | - |
| 31 Dec, 23 | 74 | -8.64% | 21,879,400 | -1.96% | 36.72% | 1.50% | 37 | -11.90% | 21 | -4.55% |
| 30 Sep, 23 | 81 | -1.22% | 22,316,970 | 0.26% | 49.46% | 1.97% | 42 | -25.00% | 22 | 29.41% |
| 30 Jun, 23 | 82 | 5.13% | 22,259,304 | 24.70% | 50.06% | 3.11% | 56 | 47.37% | 17 | -34.62% |
| 31 Mar, 23 | 78 | -7.14% | 17,850,754 | -0.70% | 40.14% | 2.14% | 38 | -9.52% | 26 | 13.04% |
| 31 Dec, 22 | 84 | -10.64% | 17,976,799 | 1.63% | 43.27% | 2.68% | 42 | -8.70% | 23 | -17.86% |
| 30 Sep, 22 | 94 | 2.17% | 17,687,867 | 1.07% | 40.17% | 2.53% | 46 | -2.13% | 28 | -3.45% |
| 30 Jun, 22 | 92 | -16.36% | 17,501,332 | -4.09% | 39.85% | 1.37% | 47 | -27.69% | 29 | 70.59% |
| 31 Mar, 22 | 110 | 22.22% | 18,248,577 | 3.47% | 53.93% | 1.94% | 65 | 32.65% | 17 | -19.05% |
| 31 Dec, 21 | 90 | -23.73% | 17,636,538 | 4.40% | 52.68% | 2.06% | 49 | - | 21 | -36.36% |
| 30 Sep, 21 | 118 | 6.31% | 16,893,682 | 3.42% | 50.52% | 2.11% | 49 | -14.04% | 33 | -2.94% |
| 30 Jun, 21 | 111 | -7.50% | 16,335,074 | -9.22% | 48.95% | 1.68% | 57 | -3.39% | 34 | -5.56% |
| 31 Mar, 21 | 120 | 6.19% | 17,994,317 | 4.79% | 53.99% | 1.79% | 59 | -1.67% | 36 | 2.86% |
| 31 Dec, 20 | 113 | 10.78% | 17,171,417 | 17.11% | 54.86% | 2.40% | 60 | 36.36% | 35 | -2.78% |
| 30 Sep, 20 | 102 | 27.50% | 14,662,588 | 4.61% | 47.84% | 2.27% | 44 | -27.87% | 36 | 200.00% |
| 30 Jun, 20 | 80 | 29.03% | 14,016,992 | 5.61% | 45.88% | 2.42% | 61 | 69.44% | 12 | -29.41% |
| 31 Mar, 20 | 62 | 24.00% | 13,271,932 | 8.82% | 43.53% | 2.72% | 36 | -7.69% | 17 | 325.00% |
| 31 Dec, 19 | 50 | 51.52% | 12,196,539 | 21.54% | 40.02% | 3.69% | 39 | 18.18% | 4 | - |
| 30 Sep, 19 | 33 | - | 10,035,118 | - | 32.92% | - | 33 | - | - | - |
IGM Biosciences Insider Shareholders Trades
Open Market Insider Trades
Open Market Insider Buys
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
Insider Sells
All Insider Owners Trades
The last insider sell of IGM Biosciences's stock was made by Hambleton Julie on Jul 29 2024, selling 15,132 shares at $14.00 per share (valued at $211.85K).
IGM Biosciences Insider Ownership Trends
All Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q1 2024 | 33 | 14 | 235.71% |
| Q4 2023 | 22 | 10 | 220.00% |
| Q3 2023 | 8 | 1 | 800.00% |
| Q2 2023 | 52 | 15 | 346.67% |
| Q1 2023 | 10 | 7 | 142.86% |
| Q4 2022 | 14 | 35 | 40.00% |
| Q3 2022 | 12 | 4 | 300.00% |
| Q2 2022 | 28 | 9 | 311.11% |
| Q1 2022 | 43 | 2 | 2150.00% |
| Q4 2021 | 22 | 7 | 314.29% |
| Q3 2021 | 12 | 14 | 85.71% |
| Q2 2021 | 19 | 26 | 73.08% |
| Q1 2021 | 36 | 25 | 144.00% |
| Q4 2020 | 37 | 19 | 194.74% |
| Q3 2020 | 29 | 11 | 263.64% |
| Q2 2020 | 15 | 5 | 300.00% |
| Q1 2020 | 14 | - | - |
| Q4 2019 | 2 | - | - |
| Q3 2019 | 45 | 29 | 155.17% |
| Q2 2003 | - | - | - |
33 total buy trades, and 14 total sell trades (buy/sell ratio of 2.36%) were made by IGM Biosciences's insiders, as of Q1 2024.
Open Market Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q1 2024 | 8 | 12 | 66.67% |
| Q4 2023 | 12 | 10 | 120.00% |
| Q3 2023 | - | 1 | - |
| Q2 2023 | 10 | 14 | 71.43% |
| Q1 2023 | - | 5 | - |
| Q4 2022 | 1 | 26 | 3.85% |
| Q3 2022 | 3 | 2 | 150.00% |
| Q2 2022 | 14 | 7 | 200.00% |
| Q1 2022 | 3 | 1 | 300.00% |
| Q4 2021 | - | 2 | - |
| Q3 2021 | - | 5 | - |
| Q2 2021 | - | 8 | - |
| Q1 2021 | - | 7 | - |
| Q4 2020 | 8 | 6 | 133.33% |
| Q3 2020 | 17 | 4 | 425.00% |
| Q2 2020 | - | - | - |
| Q1 2020 | - | - | - |
| Q4 2019 | 2 | - | - |
| Q3 2019 | 19 | - | - |
| Q2 2003 | - | - | - |
As of Q1 2024, Insider owners conducted 8 open market buy trades and 12 open market sell trades of IGM Biosciences's stocks.
IGM Biosciences Peer Ownership
| Ticker | Company |
|---|---|
| GRCL | Gracell Biotechnologies Inc. |
| CGEM | Cullinan Oncology, Inc. |
| RVMD | Revolution Medicines, Inc. Warrant |
| IKNA | Ikena Oncology, Inc. |
| MLYS | Mineralys Therapeutics, Inc. |
| STOK | Stoke Therapeutics, Inc. |
| ERAS | Erasca, Inc. |
| CERE | Cerevel Therapeutics Holdings, Inc. |
| RNA | Avidity Biosciences, Inc. |
| BDTX | Black Diamond Therapeutics, Inc. |
| BCEL | Atreca, Inc. |
| PASG | Passage Bio, Inc. |
| GLUE | Monte Rosa Therapeutics, Inc. |
| DSGN | Design Therapeutics, Inc. |
| HOWL | Werewolf Therapeutics, Inc. |
IGMS Ownership FAQ
Who Owns IGM Biosciences?
IGM Biosciences is owned by institutional shareholders (1.67%), insiders (34.70%), and public (63.63%). The largest institutional shareholder of IGM Biosciences is BAKER BROS. ADVISORS LP (6.80% of total shares) and the top mutual fund owner is T. Rowe Price New Horizons Fund, Inc. (0.37% of total shares).
Who are the major institutional shareholders of IGM Biosciences?
IGM Biosciences's major institutional shareholders are BAKER BROS. ADVISORS LP, PRICE T ROWE ASSOCIATES INC /MD/, ARTAL GROUP S.A., REDMILE GROUP, LLC, and GOLDMAN SACHS GROUP INC. The top five shareholders own together 26.45% of the company's share outstanding.
How many IGM Biosciences shareholders are there?
As of Jun 2024, there are 21 institutional shareholders of IGM Biosciences.
What percentage of IGM Biosciences is owned by BAKER BROS. ADVISORS LP?
BAKER BROS. ADVISORS LP owns 4.09M shares of IGM Biosciences, representing 6.80% of the company's total shares outstanding, valued at $28.1M (as of Jun 2024).
What percentage of IGM Biosciences is owned by PRICE T ROWE ASSOCIATES INC /MD/?
As of Jun 2024, PRICE T ROWE ASSOCIATES INC /MD/ holds 4.08M shares of IGM Biosciences (IGMS), compromising 6.78% of the company, valued at $28M.
What percentage of IGM Biosciences is owned by ARTAL GROUP S.A?
ARTAL GROUP S.A is the third largest holder of IGM Biosciences. The company owns 3.33M of the company's shares outstanding (worth $22.88M).